• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫代磷酸酯修饰的 AP613-1 用于肝癌细胞成像时可特异性靶向 GPC3。

Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging.

作者信息

Dong Lili, Zhou Hongxin, Zhao Menglong, Gao Xinghui, Liu Yang, Liu Dongli, Guo Wei, Hu Hongwei, Xie Qian, Fan Jia, Lin Jiang, Wu Weizhong

机构信息

Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China.

Department of Radiology and Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

出版信息

Mol Ther Nucleic Acids. 2018 Dec 7;13:376-386. doi: 10.1016/j.omtn.2018.09.013. Epub 2018 Sep 27.

DOI:10.1016/j.omtn.2018.09.013
PMID:30347351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6198100/
Abstract

Glypican-3 (GPC3), the cellular membrane proteoglycan, has been established as a tumor biomarker for early diagnosis of hepatocellular carcinoma (HCC). GPC3 is highly expressed in more than 70% HCC tissues detected by antibody-based histopathological systems. Recently, aptamers, a short single-strand DNA or RNA generated from systematic evolution of ligands by exponential enrichment (SELEX), were reported as potential alternatives in tumor-targeted imaging and diagnosis. In this study, a total of 19 GPC3-bound aptamers were successfully screened by capillary electrophoresis (CE)-SELEX technology. After truncated, AP613-1 was confirmed to specifically target GPC3 with a dissociation constant (K) of 59.85 nM. When modified with a phosphorothioate linkage, APS613-1 targeted GPC3 with a K of 15.48 nM and could be used as a specific probe in living Huh7 and PLC/PRF/5 imaging, GPC3-positive cell lines, but not in L02 or A549, two GPC3-negative cell lines. More importantly, Alexa Fluor 750-conjugated APS613-1 could be used as a fluorescent probe to subcutaneous HCC imaging in xenograft nude mice. Our results indicated that modified AP613-1, especially APS613-1, was a potential agent in GPC3-positive tumor imaging for HCC early diagnosis.

摘要

磷脂酰肌醇蛋白聚糖-3(GPC3)是一种细胞膜蛋白聚糖,已被确立为肝细胞癌(HCC)早期诊断的肿瘤生物标志物。基于抗体的组织病理学系统检测发现,超过70%的HCC组织中GPC3高表达。最近,适体作为一种通过指数富集的配体系统进化(SELEX)产生的短单链DNA或RNA,被报道为肿瘤靶向成像和诊断的潜在替代物。在本研究中,通过毛细管电泳(CE)-SELEX技术成功筛选出总共19种与GPC3结合的适体。经过截短后,AP613-1被证实能特异性靶向GPC3,解离常数(K)为59.85 nM。当用硫代磷酸酯键修饰后,APS613-1以15.48 nM的K值靶向GPC3,可作为活的Huh7和PLC/PRF/5成像(GPC3阳性细胞系)的特异性探针,但不能用于L02或A549这两种GPC3阴性细胞系。更重要的是,Alexa Fluor 750偶联的APS613-1可作为荧光探针用于异种移植裸鼠皮下HCC成像。我们的结果表明,修饰后的AP613-1,尤其是APS613-1,是用于HCC早期诊断的GPC3阳性肿瘤成像的潜在试剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/e62dbe4c1997/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/1c1d7259543f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/d3c3e1973342/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/916864db1800/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/8ee0be25c367/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/c45f0d076449/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/e62dbe4c1997/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/1c1d7259543f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/d3c3e1973342/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/916864db1800/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/8ee0be25c367/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/c45f0d076449/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4910/6198100/e62dbe4c1997/gr6.jpg

相似文献

1
Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging.硫代磷酸酯修饰的 AP613-1 用于肝癌细胞成像时可特异性靶向 GPC3。
Mol Ther Nucleic Acids. 2018 Dec 7;13:376-386. doi: 10.1016/j.omtn.2018.09.013. Epub 2018 Sep 27.
2
fluorescence imaging of hepatocellular carcinoma using a novel GPC3-specific aptamer probe.使用新型GPC3特异性适配体探针进行肝细胞癌的荧光成像。
Quant Imaging Med Surg. 2018 Mar;8(2):151-160. doi: 10.21037/qims.2018.01.09.
3
Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer.使用掺入吉西他滨的GPC3适配体对肝细胞癌进行靶向治疗
Pharmaceutics. 2020 Oct 18;12(10):985. doi: 10.3390/pharmaceutics12100985.
4
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.使用毛细管电泳-指数富集配体系统进化技术筛选和鉴定一种针对甲胎蛋白的新型单链DNA适配体。
Sci Rep. 2015 Oct 26;5:15552. doi: 10.1038/srep15552.
5
Development and study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma.用于肝细胞癌的双特异性磁共振成像分子探针的研制与研究。
World J Gastroenterol. 2019 Jun 28;25(24):3030-3043. doi: 10.3748/wjg.v25.i24.3030.
6
Anti-GPC3 single-chain scFv antibody acts as an agent for radio-immunoimaging in diagnosing hepatocellular carcinoma.抗GPC3单链scFv抗体作为一种用于肝细胞癌诊断的放射免疫显像剂。
Am J Transl Res. 2019 Dec 15;11(12):7422-7431. eCollection 2019.
7
Structure based innovative approach to analyze aptaprobe-GPC3 complexes in hepatocellular carcinoma.基于结构的创新方法分析肝癌中 aptaprobe-GPC3 复合物。
J Nanobiotechnology. 2022 Apr 27;20(1):204. doi: 10.1186/s12951-022-01391-z.
8
Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent Imaging.用于体内肝细胞癌荧光成像的新型磷脂酰肌醇蛋白聚糖-3结合肽
Bioconjug Chem. 2016 Mar 16;27(3):831-9. doi: 10.1021/acs.bioconjchem.6b00030. Epub 2016 Feb 19.
9
Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.通过全细胞SELEX技术鉴定用于靶向高转移性肝癌的适配体。
Oncotarget. 2016 Feb 16;7(7):8282-94. doi: 10.18632/oncotarget.6988.
10
Integrated Imaging Probe and Bispecific Antibody Development Enables In Vivo Targeting of Glypican-3-Expressing Hepatocellular Carcinoma.集成成像探针和双特异性抗体的开发实现了对表达磷脂酰肌醇蛋白聚糖-3的肝细胞癌的体内靶向。
Mol Cancer Ther. 2024 Dec 3;23(12):1815-1826. doi: 10.1158/1535-7163.MCT-23-0470.

引用本文的文献

1
Enhancing HepG2 cell apoptosis with a combined nanoparticle delivery of miR-128-3p agomir and Oroxin B: A novel drug delivery approach based on PI3K-AKT and VEGF pathway crosstalk.通过miR-128-3p激动剂和欧前胡素B的纳米颗粒联合递送增强HepG2细胞凋亡:一种基于PI3K-AKT和VEGF途径串扰的新型药物递送方法。
Asian J Pharm Sci. 2025 Jun;20(3):100909. doi: 10.1016/j.ajps.2024.100909. Epub 2024 Apr 2.
2
Recent advances in aptamer discovery, modification and improving performance.适体发现、修饰及性能提升的最新进展。
Biochem Biophys Rep. 2024 Oct 24;40:101852. doi: 10.1016/j.bbrep.2024.101852. eCollection 2024 Dec.
3

本文引用的文献

1
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.磷脂酰聚糖蛋白 3:一种有前途的肝细胞癌诊断和治疗的生物标志物。
Med Res Rev. 2018 Mar;38(2):741-767. doi: 10.1002/med.21455. Epub 2017 Jun 16.
2
Corrigendum to "LNA aptamer based multi-modal, FeO-saturated lactoferrin (FeO-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumour targeting and NIR, MRI and CT imaging" [Biomaterials 71C (2015) 84-99].《基于锁核酸适配体的多模态、FeO饱和乳铁蛋白(FeO-bLf)纳米载体用于三阳性(上皮细胞黏附分子、CD133、CD44)结肠肿瘤靶向及近红外、磁共振成像和计算机断层扫描成像》的勘误 [《生物材料》71C (2015) 84-99]
Biomaterials. 2017 Sep;138:118-120. doi: 10.1016/j.biomaterials.2017.05.041. Epub 2017 May 27.
3
Systematic bio-fabrication of aptamers and their applications in engineering biology.
适体的系统生物制造及其在合成生物学中的应用。
Syst Microbiol Biomanuf. 2023;3(2):223-245. doi: 10.1007/s43393-022-00140-5. Epub 2022 Oct 10.
4
Molecular Targets of Aptamers in Gastrointestinal Cancers: Cancer Detection, Therapeutic Applications, and Associated Mechanisms.适体在胃肠道癌症中的分子靶点:癌症检测、治疗应用及相关机制
J Cancer. 2023 Aug 6;14(13):2491-2516. doi: 10.7150/jca.85260. eCollection 2023.
5
Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma.用Gpc3适配体修饰的自然杀伤细胞增强了对肝细胞癌的过继性免疫治疗。
Discov Oncol. 2023 Sep 4;14(1):164. doi: 10.1007/s12672-023-00780-6.
6
Chemically modified aptamers for improving binding affinity to the target proteins enhanced non-covalent bonding.用于提高与靶蛋白结合亲和力的化学修饰适配体增强了非共价键合。
Front Cell Dev Biol. 2023 Feb 23;11:1091809. doi: 10.3389/fcell.2023.1091809. eCollection 2023.
7
Aptamer-mediated hollow MnO for targeting the delivery of sorafenib.适配体介导的中空 MnO 用于索拉非尼的靶向递送。
Drug Deliv. 2023 Dec;30(1):28-39. doi: 10.1080/10717544.2022.2149897.
8
Aptamers used for molecular imaging and theranostics - recent developments.适体在分子影像和治疗诊断学中的应用——最新进展。
Theranostics. 2022 May 13;12(9):4010-4050. doi: 10.7150/thno.72949. eCollection 2022.
9
Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer.使用掺入吉西他滨的GPC3适配体对肝细胞癌进行靶向治疗
Pharmaceutics. 2020 Oct 18;12(10):985. doi: 10.3390/pharmaceutics12100985.
10
Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes.适配体功能化药物纳米载体通过靶向肿瘤性肝细胞使肝癌向正常状态转变。
Mol Ther Nucleic Acids. 2020 Jun 5;20:34-49. doi: 10.1016/j.omtn.2020.01.034. Epub 2020 Feb 5.
Cancer Statistics, 2017.
《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
4
Aptamers against Cells Overexpressing Glypican 3 from Expanded Genetic Systems Combined with Cell Engineering and Laboratory Evolution.来自扩展遗传系统的针对过度表达 GPC3 的细胞的适体与细胞工程和实验室进化的结合。
Angew Chem Int Ed Engl. 2016 Sep 26;55(40):12372-5. doi: 10.1002/anie.201605058. Epub 2016 Sep 7.
5
Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.修饰后的AS1411适配体通过上调半乳糖凝集素-14抑制肝细胞癌。
PLoS One. 2016 Aug 5;11(8):e0160822. doi: 10.1371/journal.pone.0160822. eCollection 2016.
6
Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX.利用细胞 SELEX 技术生成用于纳米治疗的细胞靶向适体。
Theranostics. 2016 Jun 15;6(9):1440-52. doi: 10.7150/thno.15666. eCollection 2016.
7
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.使用毛细管电泳-指数富集配体系统进化技术筛选和鉴定一种针对甲胎蛋白的新型单链DNA适配体。
Sci Rep. 2015 Oct 26;5:15552. doi: 10.1038/srep15552.
8
LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging.基于 LNA 适体的多模态、Fe3O4 饱和乳铁蛋白(Fe3O4-bLf)纳米载体,用于三阳性(EpCAM、CD133、CD44)结肠肿瘤靶向和近红外、磁共振成像和 CT 成像。
Biomaterials. 2015 Dec;71:84-99. doi: 10.1016/j.biomaterials.2015.07.055. Epub 2015 Aug 4.
9
Notum deacylates Wnt proteins to suppress signalling activity.Notum通过去除Wnt蛋白的酰基来抑制信号活性。
Nature. 2015 Mar 12;519(7542):187-192. doi: 10.1038/nature14259. Epub 2015 Feb 25.
10
Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells.磷脂酰肌醇蛋白聚糖-3基因沉默影响人肝癌细胞的生物学行为。
Mol Med Rep. 2014 Dec;10(6):3177-84. doi: 10.3892/mmr.2014.2600. Epub 2014 Sep 26.